Phase II Study of First-line Amrubicin in Elderly Patients with Extensive Disease Small-Cell Lung Cancer (CJLSG1104) (clinicaltrials.gov) - Sep 25, 2026 - P2 | N=29 | Suspended | Sponsor: Central Japan Lung Study Group | Unknown status ➔ Suspended
Trial suspension • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor
|